We exist to improve the lives
of everyone affected by epilepsy

Mysoline/primidone to be withdrawn

29 July, 2003

Epilepsy Action has learnt that the anti-epileptic drug Mysoline (primidone) is to be withdrawn by its manufacturers from 1 December 2003.

AstraZeneca have announced a global discontinuation from that date, adding that there may be enough stock after withdrawal for the month of December only. Pharmacists and doctors have been informed.

Epilepsy Action strongly urges people taking primidone to speak to their specialist for transfer to another medication.

Users in the UK with concerns should contact:

AstraZeneca UK Ltd
Horizon Place
600 Capability Green
LUTON
Bedfordshire
LU1 3LU

Freephone 0800 8930 033

International addresses and phone numbers can be found at http://www.astrazeneca.com/node/addresses.aspx